Biocon is considering the early redemption of 1,07,000 unlisted, secured, rated, redeemable, Non-Convertible Debentures (NCDs) with a face value of INR 1,00,000 each. These NCDs, issued on February 21, 2023, are subject to board approval anticipated on October 01, 2025. The proposed redemption and further details are available on the company’s website.
Proposed Redemption of NCDs
Biocon Limited has announced a proposal to consider the early redemption of its Non-Convertible Debentures (NCDs). This move involves a total of 1,07,000 unlisted, secured, rated, and redeemable NCDs.
Details of the Debentures
The debentures in question each have a face value of INR 1,00,000. These were originally issued and allotted by the company through private placement on February 21, 2023. The proposed redemption is subject to the approval of the Board of Directors, expected to be sought on October 01, 2025.
Approval and Further Information
The company will seek the necessary approvals for this redemption. Additional details regarding the proposed redemption can be found on Biocon’s official website.
Source: BSE
